• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of April 5, 2017

    FDA

    Mylan Institutional`s Generic Bivalirudin Receives Tentative Approval In US

    FDA

    Mylan Institutional, Inc. recalls Clonazepam Tablets, USP, 0.5 mg due to failed Impurities Specifications

    FDA

    Mylan (MYL) CEO Says Pfizer (PFE) Should Come Calling, As Next Big Deal Speculation Swirls

    BIOSPACE

    Teva Sends Letter to Mylan Board.

    TEVA PHARMACEUTICAL INDUSTRIES

    Antibiotics Made By Emcure Pharmaceuticals Recalled In US

    THE ECONOMIC TIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.